AANS/CNS Section on Tumors II

Wednesday, April 17 | 2:00 pm - 5:00 pm | 30CDE; SDCC

Moderator(s): Daniel A. Orringer, MD, FAANS ; Dimitris George Placantonakis, MD, PhD, FAANS

Add to Calendar Wednesday, April 17 Wednesday, April 17 America/Chicago AANS/CNS Section on Tumors II 30CDE; SDCC

2:00 pm - 2:03 pm

Introduction to the Session: Safely Pushing the Limits of Glioma Surgery

Daniel A. Orringer, MD, FAANS

4/17/2019 2:00:00 PM 4/17/2019 2:03:00 PM Introduction to the Session: Safely Pushing the Limits of Glioma Surgery 30CDE; SDCC

2:04 pm - 2:20 pm

Integrating Molecular Data in Surgical Decision Making

Daniel P. Cahill, MD, PhD, FAANS

4/17/2019 2:04:00 PM 4/17/2019 2:20:00 PM Integrating Molecular Data in Surgical Decision Making 30CDE; SDCC

2:21 pm - 2:37 pm

Deep Seated Tumors – When to Resect and Limits

Mitchel S. Berger, MD, FAANS

4/17/2019 2:21:00 PM 4/17/2019 2:37:00 PM Deep Seated Tumors – When to Resect and Limits 30CDE; SDCC

2:38 pm - 2:54 pm

Evidence-based decision Making in Glioma Surgery: What the Literature Supports:

Colin Watts, FRCS, PhD (United Kingdom)

4/17/2019 2:38:00 PM 4/17/2019 2:54:00 PM Evidence-based decision Making in Glioma Surgery: What the Literature Supports: 30CDE; SDCC

2:55 pm - 3:11 pm

Technology to Improve Maximal Safe Resection:  5-ALA and Raman

Constantinos G. Hadjipanayis, MD, PhD, FAANS

4/17/2019 2:55:00 PM 4/17/2019 3:11:00 PM Technology to Improve Maximal Safe Resection:  5-ALA and Raman 30CDE; SDCC

3:12 pm - 3:28 pm

Case Discussion Panel

Mitchel S. Berger, MD, FAANS; Daniel P. Cahill, MD, PhD, FAANS; Constantinos G. Hadjipanayis, MD, PhD, FAANS; Colin Watts, FRCS, PhD (United Kingdom)

4/17/2019 3:12:00 PM 4/17/2019 3:28:00 PM Case Discussion Panel 30CDE; SDCC

4/17/2019 3:29:00 PM 4/17/2019 3:38:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45945"><strong>470. Stereotactic Laser Ablation for Brain Tumors: Lessons Learned from 240 Cases Over the Past Decade</strong></a> 30CDE; SDCC

4/17/2019 3:39:00 PM 4/17/2019 3:48:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=46069"><strong>471. Vorinostat for Hemangioblastomas in Germline Missense von Hippel-Lindau Disease: A Phase 0 Clinical Trial</strong></a> 30CDE; SDCC

4/17/2019 3:49:00 PM 4/17/2019 3:58:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45832"><strong>472. Sarcosine promotes trafficking of dendritic cells to draining lymph nodes and improves efficacy of a vaccine strategy for the treatment of brain tumors via CX3CL1</strong></a> 30CDE; SDCC

3:59 pm - 4:08 pm

4/17/2019 3:59:00 PM 4/17/2019 4:08:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=46134"><strong>473. Receptor discordance in breast cancer brain metastases: incidence and survival outcomes</strong></a> 30CDE; SDCC

4/17/2019 4:09:00 PM 4/17/2019 4:18:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45962"><strong>474. Radiographic Trends in Cerebral Metastases Treated with Gamma Knife Radiosurgery: Indicators for Early Intervention for Post-Gamma Knife Failures</strong></a> 30CDE; SDCC

4/17/2019 4:19:00 PM 4/17/2019 4:28:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45969"><strong>475. Human Adipose-derived Mesenchymal Stem Cell Immunomodulation of Microglia in Glioblastoma</strong></a> 30CDE; SDCC

4:29 pm - 4:32 pm

4/17/2019 4:29:00 PM 4/17/2019 4:32:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45957" style="text-decoration : none; font-weight:700">476. Tenascin-C as a Biomarker of Tumorigenesis and Treatment Response in Pediatric Diffuse Midline Glioma</a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC

4/17/2019 4:33:00 PM 4/17/2019 4:36:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=46051"><strong>477. A Novel Bioinformatics Approach to Estimate Hazard in Pediatric High Grade Glioma</strong></a> 30CDE; SDCC

4/17/2019 4:37:00 PM 4/17/2019 4:40:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45929"><strong>478. Targeting Immunostimulatory Pathways in Combination with Checkpoint Blockade Improves Survival in Murine Glioma</strong></a> 30CDE; SDCC

4/17/2019 4:41:00 PM 4/17/2019 4:44:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45792"><strong>479. Utility of the Modified Frailty Index in the Risk Stratification of Patients Undergoing Brain Tumor Resection</strong></a> 30CDE; SDCC

4/17/2019 4:45:00 PM 4/17/2019 4:48:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45953"><strong>480. Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival After Laser Induced Thermal Therapy in Glioblastoma Patients</strong></a> 30CDE; SDCC

4/17/2019 4:49:00 PM 4/17/2019 4:52:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45946"><strong>481. Vocimagene amiretrorepvec and 5 FC in Combination with Metronomic Cyclophosphamide Reduces Treg Cells and Enhances Therapy Efficacy in a Preclinical Murine Model</strong></a> 30CDE; SDCC

4/17/2019 4:53:00 PM 4/17/2019 4:56:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=45898" style="text-decoration : none; font-weight:700">482. Super-Selective Intra-Arterial Cerebral Infusion Bevacizumab for Treatment of Newly Diagnosed Glioblastoma: Phase I/II Clinical Trial Early Results</a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC

4/17/2019 4:57:00 PM 4/17/2019 5:00:00 PM <a href="./Eposter?eventid=48888&itemid=TUMOR_II_SECTION&propid=46080"><strong>483. Intraoperative Near-Infrared Imaging Accurately Detects Abnormal Intracranial Tissue</strong></a> 30CDE; SDCC